The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Kavita Sarin, MD, PhD
Dermatologist, General dermatologist, Cutaneous oncology specialist
Associate Professor of Dermatology at the Stanford University Medical Center
Bio:
Kavita Sarin, M.D./ Ph.D., is an Associate Professor of Dermatology. She has an academic interest in Personalized Medicine, focused on the integration of genetic and clinical patient data to inform disease susceptibility, stratify prognosis, and direct treatments in dermatologic disease. She sees patients in medical dermatology at Portola Valley and directs a specialized Skin Cancer Genetics clinic.
- 3240 Alpine Road
- Portola Valley , CA 94023
- Phone: 650-723-6316
- 900 Blake Wilbur Drive
- 3rd Floor
- Palo Alto , CA 94304
- Phone: 650-498-6000
- 900 Blake Wilbur Drive
- 3rd Floor
- Palo Alto , CA 94304
- Phone: 650-498-6000
Professional Education
- Internship: Santa Clara Valley Medical Center (2009) CA
- Residency: Stanford University Dept of Dermatology (2012) CA
- Board Certification: American Board of Dermatology, Dermatology (2012)
- Medical Education: Stanford University Medical Center (2008) CA
- PhD, Stanford University- Dept of Genetics, CA (2006)
- BS, Stanford University- Computer Science, CA (2000)
Honors & Awards
- Damon Runyon Clinical Investigator Award, Damon Runyon (2019-2022)
- F32 NRSA Ruth L. Kirschstein National Research Service Award, National Institutes of Health (2013-2014)
- K23 NCI Career Development Award, National Institutes of Health (2017-2022)
- Medical Dermatology Career Development Award, Dermatology Foundation (2014-2017)
- Medical Scientist Training Program Scholarship, National Institutes of Health (2000-2008)
- President's Scholar, Stanford University (1996-2000)
- Unsung Hero Award, NBC (1996)
Administrative Appointments
- Assistant Professor in Dermatology, Stanford University Medical Center (2013 - Present)
- Clinical Instructor in Dermatology, Stanford University Medical Center (2012 - 2013)
Publications
-
Conditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K. Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., … Artandi, S. E. (2005). Conditional telomerase induction causes proliferation of hair follicle stem cells. NATURE, 436(7053), 1048–52. -
Aging, graying and loss of melanocyte stem cells
Sarin, K. Y., & Artandi, S. E. (2007). Aging, graying and loss of melanocyte stem cells. STEM CELL REVIEWS, 3(3), 212–17. -
TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program
Choi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., … Artandi, S. E. (2008). TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLOS GENETICS, 4(1). -
Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.
Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (2012). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nature Medicine, 18(1), 111–119.
-
Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab
Sarin, K. Y., & Fiorentino, D. (2012). Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, 148(9), 990–92.
-
Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome
Sun, B. K., Saggini, A., Sarin, K. Y., Kim, J., Benjamin, L., LeBoit, P. E., & Khavari, P. A. (2013). Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133(3), 824–27.
-
Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin, K. Y., Sun, B. K., Bangs, C. D., Cherry, A., Swetter, S. M., Kim, J., & Khavari, P. A. (2013). Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatology , 149(9), 1077–81.
-
Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. Journal of the American Academy of Dermatology, 70(2), e47–8.
-
Activating HRAS Mutation in Nevus Spilus.
Sarin, K. Y., McNiff, J. M., Kwok, S., Kim, J., & Khavari, P. A. (2014). Activating HRAS Mutation in Nevus Spilus. Journal of Investigative Dermatology, 134(6), 1766–68.
-
Dermatomyositis associated with capecitabine in the setting of malignancy
Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(2), E47–E48.
-
Smoothened variants explain the majority of drug resistance in Basal cell carcinoma.
Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., … Tang, J. Y. (2015). Smoothened variants explain the majority of drug resistance in Basal cell carcinoma. Cancer Cell, 27(3), 342–53.
-
Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma.
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., … de Sauvage, F. J. (2015). Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma. Cancer Cell, 27(3), 327–41.
-
Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma.
Atwood, S. X., Sarin, K. Y., Li, J. R., Yao, C. Y., Urman, N. M., Chang, A. L. S., … Oro, A. E. (2015). Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. Journal of Investigative Dermatology, 135(8), 2138–41.
-
Dermatologic applications of direct-to-consumer genomic analysis.
Fogel, A. L., Azizi, N., Tang, J., & Sarin, K. Y. (2014). Dermatologic applications of direct-to-consumer genomic analysis. Journal of the American Academy of Dermatology, 71(5), 993–95.
-
A subdermal source: contact dermatitis.
Fogel, A. L., Longmire, M., Rieger, K. E., & Sarin, K. Y. (2015). A subdermal source: contact dermatitis. American Journal of Medicine, 128(6), 578–81.
-
Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis
Sarin, K., Chung, L., Kim, J., Higgs, B. W., Jallal, B., Yao, Y., & Fiorentino, D. (2013). Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis. Journal of Investigative Dermatology, 133(12).
-
Squamous Change in Basal-Cell Carcinoma with Drug Resistance.
Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2015). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. New England Journal of Medicine, 373(11), 1079–82.
-
Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma.
Jaju, P. D., Nguyen, C. B., Mah, A. M., Atwood, S. X., Li, J., Zia, A., … Sarin, K. Y. (2015). Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. Journal of Investigative Dermatology, 135(12), 3197–3200.
-
Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma.
Ransohoff, K. J., Sarin, K. Y., & Tang, J. Y. (2015). Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Journal of Clinical Oncology , 33(24), 2692–94.
-
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
Ally, M. S., Ransohoff, K., Sarin, K., Atwood, S. X., Rezaee, M., Bailey-Healy, I., … Colevas, A. D. (2016). Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA Dermatology, 152(4), 452–56.
-
Squamous Change in Basal-Cell Carcinoma with Drug Resistance
Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2015). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. NEW ENGLAND JOURNAL OF MEDICINE, 373(11), 1079–82.
-
Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors
Sarin, K. Y., Tang, J. Y., Ransohoff, K. J., & Jaju, P. D. (2016). Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. Journal of The American Academy of Dermatology, 74(3).
-
Familial skin cancer syndromes: Increased melanoma risk
Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2016). Familial skin cancer syndromes: Increased melanoma risk. Journal of The American Academy of Dermatology, 74(3).
-
Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma
Sarin, K. Y., Ally, M. S., Ransohoff, K. J., Atwood, S. X., & Rezaee, M. (2016). Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma. JAMA Dermatology, 1–5.
-
An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib
Sarin, K. Y., Oro, A. E., Chang, A. L., & Danial, C. (2015). An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research.
-
A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy
Fogel, A. L., & Sarin, K. Y. (2016). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy. Journal of Telemedicine and Telecare, (January).
-
The digital age of melanoma management: detection and diagnostics
Fogel, A. L., & Sarin, K. Y. (2015). The digital age of melanoma management: detection and diagnostics. Future Medicine, 2(4).
-
Familial skin cancer syndromes Increased melanoma risk
Ransohoff, K. J., Jaju, P. D., Tang, J. Y., Carbone, M., Leachman, S., & Sarin, K. Y. (2016). Familial skin cancer syndromes Increased melanoma risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), 423–34.
-
Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors
Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2016). Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), 437–51.
-
An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
Danial, C., Sarin, K. Y., Oro, A. E., & Chang, A. L. S. (2016). An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib. CLINICAL CANCER RESEARCH, 22(6), 1325–29.
-
Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching.
Ransohoff, J. D., Li, S., & Sarin, K. Y. (2016). Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching. JAMA Dermatology, 152(10), 1164–66.
-
Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.
Chahal, H. S., Wu, W., Ransohoff, K. J., Yang, L., Hedlin, H., Desai, M., … Sarin, K. Y. (2016). Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma. Nature Communications, 7, 12510-?
-
Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets.
Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, K. Y. (2016). Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets. Journal of Investigative Dermatology, 136(7), 1517–20.
-
Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.
Chahal, H. S., Lin, Y., Ransohoff, K. J., Hinds, D. A., Wu, W., Dai, H.-ji, … Sarin, K. Y. (2016). Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma. Nature Communications, 7, 12048-?
-
Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling
Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (2012). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. NATURE MEDICINE, 18(1), 111–19.
-
Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma.
Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (2016). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. Pediatric Dermatology.
-
Direct-to-consumer teledermatology services for pediatric patients: Room for improvement.
Fogel, A. L., Teng, J., & Sarin, K. Y. (2016). Direct-to-consumer teledermatology services for pediatric patients: Room for improvement. Journal of the American Academy of Dermatology, 75(5), 887–88.
-
Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions
Urman, N. M., Mirza, A., Atwood, S. X., Whitson, R. J., Sarin, K. Y., Tang, J. Y., & Oro, A. E. (2016). Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions. PLOS ONE, 11(12).
-
Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk.
Fogel, A. L., Jaju, P. D., Li, S., Halpern-Felsher, B., Tang, J. Y., & Sarin, K. Y. (2017). Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk. Journal of the American Academy of Dermatology.
-
Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age.
Chahal, H. S., Rieger, K. E., & Sarin, K. Y. (2017). Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. Journal of the American Academy of Dermatology, 76(2), 353–54.
-
Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Dai, H., … Han, J. (2017). Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma. International Journal of Cancer.
-
A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy.
Fogel, A. L., & Sarin, K. Y. (2017). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy. Journal of Telemedicine and Telecare, 23(1), 19–25.
-
Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
Ransohoff, K. J., Wu, W., Cho, H. G., Chahal, H. C., Lin, Y., Dai, H.-ji, … Sarin, K. Y. (2017). Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. Oncotarget.
-
Basosquamous Carcinoma: Controversy, Advances, and Future Directions.
Tan, C. Z., Rieger, K. E., & Sarin, K. Y. (2017). Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatologic Surgery , 43(1), 23–31.
-
Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma
Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (2017). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. PEDIATRIC DERMATOLOGY, 34(1), E35–E36.
-
Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Song, F., … Han, J. (2017). Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma. International Journal of Cancer.
-
Genetic diseases associated with an increased risk of skin cancer development in childhood.
Fogel, A. L., Sarin, K. Y., & Teng, J. M. C. (2017). Genetic diseases associated with an increased risk of skin cancer development in childhood. Current Opinion in Pediatrics.
-
Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Nevus Syndrome.
Cai, E. D., Sun, B. K., Chiang, A., Rogers, A., Bernet, L., Cheng, B., … Sarin, K. Y. (2017). Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Nevus Syndrome. Journal of Investigative Dermatology.
-
Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution.
Kuo, K. Y., Batra, P., Cho, H. G., Li, S., Chahal, H. S., Rieger, K. E., … Sarin, K. Y. (2017). Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution. Journal of the American Academy of Dermatology.
-
IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.
Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., … Anandasabapathy, N. (2017). IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Cell, 170(1), 127–41.e15.
-
Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.
Mirza, A. N., Fry, M. A., Urman, N. M., Atwood, S. X., Roffey, J., Ott, G. R., … Oro, A. E. (2017). Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment. JCI Insight, 2(21).
-
Genomic Stability in Syndromic Basal Cell Carcinoma.
Chiang, A., Jaju, P. D., Batra, P., Rezaee, M., Epstein, E. H., Tang, J. Y., & Sarin, K. Y. (2017). Genomic Stability in Syndromic Basal Cell Carcinoma. The Journal of Investigative Dermatology.
-
Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
Whitson, R. J., Lee, A., Urman, N. M., Mirza, A., Yao, C. Y., Brown, A. S., … Oro, A. E. (2018). Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nature Medicine, 24(3), 271–81.
-
Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.
Ransohoff, J. D., Nikfarjam, A., Jones, E., Loew, B., Kwong, B. Y., Sarin, K. Y., & Shah, N. H. (2018). Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning. JAMA Oncology, 4(4), 581–83.
-
Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort.
Cho, H. G., Ransohoff, K. J., Yang, L., Hedlin, H., Assimes, T., Han, J., … Sarin, K. Y. (2018). Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. Journal of the American Academy of Dermatology.
-
Azathioprine and risk of multiple keratinocyte cancers.
Cho, H. G., Kuo, K. Y., Xiao, K., Batra, P., Li, S., Tang, J. Y., & Sarin, K. Y. (2018). Azathioprine and risk of multiple keratinocyte cancers. Journal of the American Academy of Dermatology, 78(1), 27–28.e1.
-
TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma.
Kuonen, F., Surbeck, I., Sarin, K. Y., Dontenwill, M., Ruegg, C., Gilliet, M., … Gaide, O. (2018). TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma. The Journal of Investigative Dermatology.
-
Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes
Ko, J. S., Matharoo-Ball, B., Billings, S. D., Thomson, B. J., Tang, J. Y., Sarin, K. Y., … Clarke, L. E. (2017). Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 26(7), 1107–13.
-
Identification of Atorvastatin for Moderate to Severe Hidradenitis through Drug Repositioning Using Public Gene Expression Datasets
Kuo, K. Y., Cho, H. G., & Sarin, K. Y. (2018). Identification of Atorvastatin for Moderate to Severe Hidradenitis through Drug Repositioning Using Public Gene Expression Datasets. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), 1209–12.
-
Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility
Cho, H. G., Kuo, K. Y., Li, S., Bailey, I., Aasi, S., Chang, A. L. S., … Sarin, K. Y. (2018). Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility. JCI INSIGHT, 3(15).
-
Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study.
Chang, A. L., Tran, D. C., Cannon, J. G., Li, S., Jeng, M., Patel, R., … Colevas, A. D. (2018). Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study. Journal of the American Academy of Dermatology.
-
Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk
Wu, W., Amos, C. I., Lee, J. E., Wei, Q., Sarin, K. Y., & Han, J. (2018). Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(9), 2072–75.
-
Automated Classification of Skin Lesions: From Pixels to Practice.
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J. (2018). Automated Classification of Skin Lesions: From Pixels to Practice. The Journal of Investigative Dermatology, 138(10), 2108–10.
-
Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from 1973-2014.
Cai, E. D., Swetter, S. M., & Sarin, K. Y. (2018). Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from 1973-2014. Journal of the American Academy of Dermatology.
-
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Pastorino, S., Yoshikawa, Y., Pass, H. I., Emi, M., Nasu, M., Pagano, I., … Carbone, M. (2018). A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2018790352.
-
Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.
Sargen, M. R., Cloutier, J. M., Sarin, K. Y., Rieger, K. E., Chu, P., Swetter, S. M., & Novoa, R. A. (2019). Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma. Pigment Cell & Melanoma Research.
-
Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma.
Kuonen, F., Huskey, N. E., Shankar, G., Jaju, P., Whitson, R. J., Rieger, K. E., … Oro, A. E. (2019). Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma. The Journal of Investigative Dermatology.
-
Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations.
Kim, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Sarin, K. Y., & Teng, J. (2019). Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations. PloS One, 14(4), e0213872.
-
The digital age of melanoma management: detection and diagnostics.
Fogel, A. L., & Sarin, K. (2015). The digital age of melanoma management: detection and diagnostics. Melanoma Management, 2(4), 383–91.
-
Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations
Kim, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Sarin, K. Y., & Teng, J. (2019). Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations. PLOS ONE, 14(4).
-
Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.
Jia, J. L., Polin, D. J., & Sarin, K. Y. (2019). Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care. Seminars in Cutaneous Medicine and Surgery, 38(1), E57–E53.
-
Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma
Sargen, M. R., Cloutier, J. M., Sarin, K. Y., Rieger, K. E., Chu, P., Swetter, S. M., & Novoa, R. A. (2019). Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma. PIGMENT CELL & MELANOMA RESEARCH, 32(3), 474–78.
-
Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection.
Nikfarjam, A., Ransohoff, J. D., Callahan, A., Jones, E., Loew, B., Kwong, B. Y., … Shah, N. H. (2019). Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection. JMIR Public Health and Surveillance, 5(2), e11264.
-
Genetic mutations underlying phenotypic plasticity in basosquamous carcinoma
Chiang, A., Tan, C. Z., Kuonen, F., Hodgkinson, L. M., Chiang, F., Cho, R. J., … Sarin, K. Y. (2019). Genetic mutations underlying phenotypic plasticity in basosquamous carcinoma. Journal of Investigative Dermatology.
-
Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma
Kuonen, F., Huskey, N. E., Shankar, G., Jaju, P., Whitson, R. J., Rieger, K. E., … Oro, A. E. (2019). Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(7), 1439–48.
-
Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.
Sohn, G. K., Kwon, G. P., Bailey-Healy, I., Mirza, A., Sarin, K., Oro, A., & Tang, J. Y. (2019). Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial. JAMA Dermatology.
-
Response to Clarifying the Current Understanding of Syndromic Basal Cell Carcinomas.
Chiang, A., Batra, P., & Sarin, K. Y. (2019). Response to Clarifying the Current Understanding of Syndromic Basal Cell Carcinomas. The Journal of Investigative Dermatology.
-
Clonal replacement of tumor-specific T cells following PD-1 blockade.
Yost, K. E., Satpathy, A. T., Wells, D. K., Qi, Y., Wang, C., Kageyama, R., … Chang, H. Y. (2019). Clonal replacement of tumor-specific T cells following PD-1 blockade. Nature Medicine.
-
Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment
Nayyar, P. M., Chang, A. L. S., Sarin, K., & Ratner, D. (2019). Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment. DERMATOLOGIC SURGERY, 45(4), 608–10.
-
Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis.
Hua, V. J., Kuo, K. Y., Cho, H. G., & Sarin, K. Y. (2019). Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis. Journal of the American Academy of Dermatology.
-
Assessment of readability and content of patient-initiated google search results for epidermolysis bullosa.
Jia, J. L., Nguyen, B., & Sarin, K. Y. (2019). Assessment of readability and content of patient-initiated google search results for epidermolysis bullosa. Pediatric Dermatology.
-
A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas
Chang, A., Duy Tran, Cannon, J., Li, S., Jeng, M., Rieger, K., … Colevas, D. (2019). A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 81(4), AB8.
-
Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care
Jia, J. L., Polin, D. J., & Sarin, K. Y. (2019). Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 38(1), E57–E63.
-
Comparing Online Engagement and Academic Impact of Dermatology Research: An Altmetric Attention Score and PlumX Metrics Analysis.
Jia, J. L., Nguyen, B., Mills, D. E., Polin, D. J., & Sarin, K. Y. (2019). Comparing Online Engagement and Academic Impact of Dermatology Research: An Altmetric Attention Score and PlumX Metrics Analysis. Journal of the American Academy of Dermatology.
-
From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (2019). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 12, 933–42.
-
From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (2019). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Clinical, Cosmetic and Investigational Dermatology, 12, 933–42.
-
Skin Disease Activity and Autoantibody Phenotype Are Major Determinants of Blood Interferon Signatures in Dermatomyositis
Tabata, M., Sarin, K., Page, K., Huard, C., Zhao, S., Bennett, D., … Fiorentino, D. (2019). Skin Disease Activity and Autoantibody Phenotype Are Major Determinants of Blood Interferon Signatures in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 71.
-
A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis
Kim, Y. J., Schiopu, E., Danko, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. (2019). A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 71.
-
Angular compounding for speckle reduction in optical coherence tomography using geometric image registration algorithm and digital focusing.
Zhao, J., Winetraub, Y., Yuan, E., Chan, W. H., Aasi, S. Z., Sarin, K. Y., … de la Zerda, A. (2020). Angular compounding for speckle reduction in optical coherence tomography using geometric image registration algorithm and digital focusing. Scientific Reports, 10(1), 1893.
-
Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma.
Sarin, K. Y., Lin, Y., Daneshjou, R., Ziyatdinov, A., Thorleifsson, G., Rubin, A., … Han, J. (2020). Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nature Communications, 11(1), 820.
-
Ways to Improve Care for LGBT Patients in Dermatology Clinics.
Jia, J. L., Polin, D. J., & Sarin, K. Y. (2020). Ways to Improve Care for LGBT Patients in Dermatology Clinics. Dermatologic Clinics, 38(2), 269–76.
-
Sexual and Gender Minority Curricula Within US Dermatology Residency Programs.
Jia, J. L., Nord, K. M., Sarin, K. Y., Linos, E., & Bailey, E. E. (2020). Sexual and Gender Minority Curricula Within US Dermatology Residency Programs. JAMA Dermatology.
-
Gamification improves melanoma visual identification among high school students: Results from a randomized study.
Jia, J. L., Shen, A., Tabata, M. M., & Sarin, K. Y. (2020). Gamification improves melanoma visual identification among high school students: Results from a randomized study. Pediatric Dermatology.
-
Fitzpatrick Phototype Disparities in Identification of Cutaneous Malignancies by Google Reverse Image.
Jia, J. L., Wang, J. Y., Mills, D. E., Shen, A., & Sarin, K. Y. (2020). Fitzpatrick Phototype Disparities in Identification of Cutaneous Malignancies by Google Reverse Image. Journal of the American Academy of Dermatology.
-
Prevalence and risk factors for high frequency basal cell carcinoma in the United States.
Chiang, A., Solis, D. C., Rogers, H., Sohn, G. K., Cho, H. G., Saldanha, G., … Tang, J. Y. (2020). Prevalence and risk factors for high frequency basal cell carcinoma in the United States. Journal of the American Academy of Dermatology.
-
A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis.
Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. Y. (2020). A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis. Journal of the American Academy of Dermatology.
-
Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry.
Tabata, M. M., Li, S., Knight, P., Bakker, A., & Sarin, K. Y. (2020). Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight, 5(16).
-
AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.
Yao, C. D., Haensel, D., Gaddam, S., Patel, T., Atwood, S. X., Sarin, K. Y., … Oro, A. E. (2020). AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma. Nature Communications, 11(1), 5079.
-
Patient Crowdfunding for the Treatment of Cutaneous Malignancies.
Jia, J. L., Mills, D. E., Urman, N. M., & Sarin, K. Y. (2020). Patient Crowdfunding for the Treatment of Cutaneous Malignancies. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.].
-
Crowdfunding for the treatment of cutaneous malignancies: Trends, correlates, and money raised
Jia, J. L., Mills, D., & Sarin, K. Y. (2020). Crowdfunding for the treatment of cutaneous malignancies: Trends, correlates, and money raised. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83(6), AB107.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Oct 2020
Dr Sarin is excellent - very thorough, professional, and friendly. She takes time to discuss my health problem with my and why she's doing the procedures she's doing. I feel she's interested in my health.
SHC Patient, Oct 2020
She's the best!
SHC Patient, Sep 2020
I drove all the way from Modesto to Portola Valley just to see Dr. Sarin. She is outstanding in her field. She has a very positive demeanor and wonderful feeling tone. Very knowledgeable in her area! (Dermatology.)
SHC Patient, Aug 2020
As always, Dr. Sarin is an outstanding physician, caring with an excellent skills as a physician
SHC Patient, Aug 2020
Dr. Sarin is excellent.
SHC Patient, Aug 2020
Dr. Sarin is fantastic.. Her student Dr. Tu was excellent.
SHC Patient, Aug 2020
Consistently professional.
SHC Patient, Aug 2020
Dr. Sarvin is caring, efficient, knowledgeable.
SHC Patient, Jul 2020
Dr Sarin always explains everything clearly. She remembers medical and non-medical topics we've discussed in the past (which I find amazing, given the number of patients she deals with). Excellent bedside manner!
SHC Patient, May 2020
Dr. Sarin was courteous, friendly, professional, and thorough. I felt she was genuinely interested in me and my concerns. I would recommend her to any new patient.
SHC Patient, Apr 2020
Good experience.
SHC Patient, Mar 2020
Dr. Sarin is very thoughtful and responds to our concerns. She is also very thorough.
SHC Patient, Jan 2020
Dr. Sarin is fantastic
SHC Patient, Dec 2019
Dr. Sarin is amazing.
SHC Patient, Nov 2019
Not as thorough as past experience with other providers.
SHC Patient, Nov 2019
love Dr. Sarin and feel blessed to be in her care. Thank you so much!
SHC Patient, Nov 2019
Dr. Sarin is awesome!
SHC Patient, Oct 2019
good bedside mannerswelcoming
SHC Patient, Oct 2019
Dr. Sarin was very good in diagnosing my skin condition, and she gave me very good treatment recommendations
SHC Patient, Sep 2019
She has very good bedside manners. She is also very informative with my issues. Learn something new that the other doctors never mention. Wish she practice closer to my location. I was very happy with the care she has given me that day.
SHC Patient, Aug 2019
Dr. Sarin is excellent. She put me at ease, very patient, kind, upbeat, professional and thorough.
SHC Patient, Aug 2019
Exceptional experience
SHC Patient, Aug 2019
Dr Kavita is the best dermatologist on the Face ID the earth . She has detected many issues with my skin and always have the right solution.
SHC Patient, Aug 2019
Dr Sarin is thoughtful in terms of my care, she's smart, compassionate and spends lots of time with me
SHC Patient, Aug 2019
Dr Sarin is a great doctor. I've seen her a few times and she is always pleasant, knowledgeable and does a great job.
SHC Patient, Jul 2019
Dr. Sarin was wonderful!
SHC Patient, Jul 2019
dr sarin is fabulous. she greets you like she is seeing her best friend
SHC Patient, Jun 2019
My overall experience was excellent. Dr. Sarin is a fantastic doctor!
SHC Patient, Jun 2019
Both, the Resident and the Attending were great, friendly and explained well my problem and options. Great service!
SHC Patient, May 2019
Dr. Sarin is outstanding
SHC Patient, Apr 2019
Dr. Sarin has the extraordinary gift of masterful use of clearly-articulated discourse to illuminate for the patient a complex network of connections between symptoms and potential causes, unveiling in a very friendly and easily-comprehensible manner her medical reasoning from premise to conclusion, and thus providing the patient with a clear understanding of the situation, crystal-clear explanation of plan of assessment and treatment, and precise instructions for after-visit care. I have rarely met a medical professional with such an outstanding capacity to communicate clearly and to the point all the relevant information, while also listening and pertinently responding to questions.
SHC Patient, Apr 2019
Dr Sarin is a bright light in medicine.
SHC Patient, Mar 2019
Dr. Sarin is an incredible talent & personality.
SHC Patient, Mar 2019
Dr. Sarin is outstanding.
SHC Patient, Mar 2019
Dr Sarin is amazing. Patient, kind, works with me as a team
SHC Patient, Jan 2019
I have passed on the good service this dept. provides. Many people from the Sequoias already attend here.
SHC Patient, Dec 2018
Answers questions caring attitude.
SHC Patient, Sep 2018
I am very happy and confident with my care provider! I highly recommend her with my friends and family!!
SHC Patient, Sep 2018
While she told me that the condition I have and the treatments necessary were not something she could treat, she gave me information and follow up info for someone who might be able to help.
SHC Patient, Jul 2018
Good.
SHC Patient, Jun 2018
dr Sarin is an incredibly fine physician. thank you.
SHC Patient, Jun 2018
Dr Sarin was as professional and empathetic as she3 could be1
SHC Patient, Jun 2018
Dr Sarin is great!
SHC Patient, May 2018
my providers are awesome and true professionals
SHC Patient, Mar 2018
Excellent doctor. Dr. Sarin is wonderful, very very good.
SHC Patient, Mar 2018
Outstanding!
SHC Patient, Feb 2018
Fantastic Doctor Dr Kavita
SHC Patient, Feb 2018
Dr.Sarin is a GREAT Doc - I am fortunate to have her as my dermatologist
SHC Patient, Jan 2018
Dr. Sarin is the best dermatologist I have been to. And I have 30 years of derm visits! She is wonderful.
SHC Patient, Jan 2018
Kavita is amazing. She's got great energy and always has a big smile! I love the way she works with you to figure out the best path in a collaborative method. The best doctor I've ever worked with!
SHC Patient, Dec 2017
I felt very well considered and cared for. Even got to listen to Classical music during my surgery. They were both really great and accommodating, answering questions, letting me take a look at the mass they removed when I asked, and really making sure everything went well. Really excellent care, which is to be expected with Stanford!
SHC Patient, Nov 2017
Dr. Kavita Sarin is an outstanding dermatologist. I am convinced of her competence. She exudes knowledge and shares it freely and with kindness. She is so professional and up to date on the minutest details of her profession. She can explain things on the microbiology level to the huge picture so well. She was referred to me as a superb physician by an outstanding dermatologist who we had under our PPO and there is no doubt she exceeds the referral if that is possible! I am very grateful to be under her care for my dermatology needs.
SHC Patient, Oct 2017
They are always wonderful.
SHC Patient, Oct 2017
Dr. Sarin is a perfect combination of friendly-but-efficient and knowledgeable-but-concise. And also thorough in reviewing notes and issues from previous visits.
SHC Patient, Aug 2017
Dr Sarin is excellent! Patient with me, calm, passionate, and make correct diagnosis! I'm lucky to have her as my doctor
SHC Patient, Aug 2017
Dr Sarin addressed my concerns in great detail and I left the clinic feeling empowered about the information she gave me from her exam
SHC Patient, Aug 2017
Overall, it was good but nothing special. The doctor took time to answer all my questions and this was important but left as soon as she finished answering and I was left alone in the room wondering what I was supposed to do next! So, I changed and went back to the front desk by myself --- felt a bit strange.
SHC Patient, Aug 2017
Dr. Sarin is fantastic. She is very professional,kind and caring. I'm delighted I've found a dermatologist I am totally confident in and look forward to my next check up!
SHC Patient, Aug 2017
Dr. Sarin is highly personable and attentive. What a gem! I very much appreciate her service.
SHC Patient, Jul 2017
Dr. Sarin is the VERY BEST!!!
SHC Patient, Jul 2017
Dr. Sarin provided me with excellent care. she addressed every skin condition I was concerned about and treated them right then and there. I raved about Dr. Sarin to my husband and I'm hoping that they will accept him as a new patient as well. She is lovely, very personable, caring and extremely efficient.
SHC Patient, Jun 2017
Dr. Sarin is very nice, professional & knowledgeable. She is also very patient with me. Very good doctor. Already recommend her to other friends.
SHC Patient, Jun 2017
Dr. Sarin is great. She has a 10+ of knowledge in her field and has good suggestions. Very good at explaining new options for medicine too.
SHC Patient, May 2017
It was far and she was great. Wish I'd qualified for the clinical trial, but it isn't her fault my condition decided to go into remission, heh!
SHC Patient, Apr 2017
They are awesome.
SHC Patient, Apr 2017
Dr. Sarin has a very caring manner. She is an extremely pleasant person.
SHC Patient, Mar 2017
Dr. Sarin was friendly, clear, professional and empathetic. I was impressed with both her and the intern and how they worked together! thank you Dr. Sarin.
SHC Patient, Mar 2017
Dr Sarin is a superb doctor.
SHC Patient, Feb 2017
Dr Sarin is extremely knowledge. She is caring and has great bedside manner. I cannot ask for any better doctor.
SHC Patient, Feb 2017
Dr. Sarin is one of the best doctors I have ever had.
SHC Patient, Feb 2017
Dr Sarin is great
SHC Patient, Feb 2017
I have no complaint all was very good.
SHC Patient, Feb 2017
Once I got to see Dr. Sarin, she was terrific.
SHC Patient, Jan 2017
I love the way things are done here
SHC Patient, Dec 2016
Dr. Sarin exuded confidence so I was reassured from the beginning that my problems would be resolved as well as possible. She was efficient, friendly - just what a patient wants in a care provider.
SHC Patient, Dec 2016
No concerns. Everything went smoothy with great communication.
SHC Patient, Nov 2016
Detailed and helpful
SHC Patient, Nov 2016
Dr Sarin is a great listener, shows genuine concern, and is open to patient input
SHC Patient, Nov 2016
Dr. Sarin & her resident are excellent.
SHC Patient, Nov 2016
Dr. Sarin is a superb doctor I could not ask for a better dermatologist.
SHC Patient, Oct 2016
The doctors are courteous, patient and very professional. At no point did I feel discomfort to discuss any issues or ask questions. We discussed several medications and I was able to make a decision on what seemed right for me. I definitely recommend the Portola clinic to anyone.
SHC Patient, Oct 2016
My one comment about Dr. Sarin is that she speaks very fast. She is very confident and competent, but it was a great deal of new information and vocabulary for me (a well-educated patient), so it was difficult for me to understand and follow her.
SHC Patient, Oct 2016
As usual utmost professionalism applied.
SHC Patient, Oct 2016
Dr. Sarin was very good and very knowledgeable. My only observation is that she talks a little too quickly, making it a little difficult to follow her, especially when medical terminology is used.
SHC Patient, Oct 2016
very good over all experience
SHC Patient, Sep 2016
excellent dermatologist
SHC Patient, Aug 2016
dr was amazing
SHC Patient, Aug 2016
Most Drs are pretty bright. Dr Sarin is VERY bright. As a research scientist she is on top of the latest developments in the field. I've seen her twice, both times she's asked if I have questions on anything and then spent the time to fully explain the answer.
SHC Patient, Aug 2016
Dr Sarin is the best.
SHC Patient, Aug 2016
Doctor & assistant were the best.
SHC Patient, Jul 2016
Dr. Sarin was superb!
SHC Patient, Jun 2016
Dr. Sarin is the "best of the best."
SHC Patient, Jun 2016
It was worth waiting two months to see her.
SHC Patient, Jun 2016
I understood some/many of the dermatology vocabulary. Dr. Sheu & Sarin were not "rushing out the door' and provided time to answer my questions. Dr. Sheu was patient and Dr. Sarin also provided time.
SHC Patient, Jun 2016
I felt heard and cared for. Dr. Sarin did not seem in any rush to get me in and out. She focused on me.
SHC Patient, May 2016
Dr. Sarin is wonderful, very wonderful.
SHC Patient, May 2016
Dr. Sarin was excellent, listened to all of my concerns, took the time to explain everything to me, and let me make informed decisions about medication options. I've already recommended Dr. Sarin to colleagues.
SHC Patient, May 2016
Dr. Sarin and Resident Dr. Sarah were both wonderful. I can't say enough about these two splendid people.
SHC Patient, Apr 2016
I was impressed that Dr. Sarin did not rush the appointment. She was very thorough.
SHC Patient, Apr 2016
I have recommended Dr. Sarin to others!
SHC Patient, Apr 2016
it would be helpful for the Care provider to use words that the patient could understand.
SHC Patient, Mar 2016
Such incredible, high quality dermatologist!
SHC Patient, Mar 2016
I did recommend her
SHC Patient, Mar 2016
She is very, very nice!
SHC Patient, Feb 2016
Dr. Savin very knowledgeable and explained well my treatment options. We together chose one treatment that best fit my situation and what I was willing to do.
SHC Patient, Feb 2016
The doctor and I were both prepared for the appointment because of correspondence using the app!
SHC Patient, Jan 2016
positive
SHC Patient, Dec 2015
Very thorough job with special emphasis on my issues. Super job.
SHC Patient, Nov 2015
Excellent Clinician
SHC Patient, Nov 2015
Dr. Sarin is exceptional. She seems extremely intelligent and has a wonderful manner.
SHC Patient, Oct 2015
Care provider was knowledgeable and kind but very late.
SHC Patient, Oct 2015
Wonderful care and concern!
SHC Patient, Sep 2015
Dr. Sarin was very helpful and clear.
SHC Patient, Sep 2015
Again, Dr. Sarin the best ! Already referred two people to her and they too are very happy.
SHC Patient, Aug 2015
Very capable and knowledgeable. I am very enthusiastic about this doctor.
SHC Patient, Aug 2015
Appreciate dr sarin!
SHC Patient, Jul 2015
During this visit I had two biopsies. The results of these biopsies from the lab doctor were totally over my head. I had to ask the doctor what was meant. She told me in simple terms. "No problem."
SHC Patient, Jul 2015
Dr. Sarin is outstanding
SHC Patient, Jun 2015
Was not specific about medications recommended, information she said she was going to give or follow-up instructions.
SHC Patient, Jun 2015
she seemed rushed otherwise very nice and very educated
SHC Patient, Jun 2015
Responsive, caring, A#1,
SHC Patient, May 2015
We have recommended Dr. Sarin to others in our community.
SHC Patient, Apr 2015
Dr. Sarin exemplifies true professionalism - knowledge, communication & personality!
SHC Patient, Mar 2015
Excellent and very knowledgeable.
SHC Patient, Mar 2015
The student intern provided an assessment then the dermatologist came in to discuss and review the assessment.
SHC Patient, Feb 2015
Dr. Sarin is personable and completely professional.
SHC Patient, Feb 2015
Very good. I look forward to seeing Dr. Sarin again.
SHC Patient, Dec 2014
I felt very well taken care of.
SHC Patient, Oct 2014
I having V good experience.
SHC Patient, Oct 2014
Care provider shows a really caring attitude toward her patient.
SHC Patient, Oct 2014
Very good experience.
SHC Patient, Aug 2014
Dr. Sarin provided a very knowledgeable diagnosis; thorough guidance.
SHC Patient, Jun 2014
Dr. especially helpful, informative.
SHC Patient, Jun 2014
I am more than satisfied with the care provided by Dr. Sarin.
SHC Patient, Mar 2014
Dr. Kavita Sarin is excellent!
SHC Patient, Mar 2014
Would like a complete, in-depth explanation of condition and causes, not just need to know treatment. Holistic treatment options (e.g., diet changes, exercise) should be discussed in addition to traditional western medicine.
SHC Patient, Jan 2014
Did not seem to understand my needs. At the end of the appointment she realized I actually needed to seen an allergy specialist.
SHC Patient, Oct 2020
Dr Sarin is excellent - very thorough, professional, and friendly. She takes time to discuss my health problem with my and why she's doing the procedures she's doing. I feel she's interested in my health.
SHC Patient, Oct 2020
She's the best!
SHC Patient, Sep 2020
I drove all the way from Modesto to Portola Valley just to see Dr. Sarin. She is outstanding in her field. She has a very positive demeanor and wonderful feeling tone. Very knowledgeable in her area! (Dermatology.)
SHC Patient, Aug 2020
As always, Dr. Sarin is an outstanding physician, caring with an excellent skills as a physician
SHC Patient, Aug 2020
Dr. Sarin is excellent.
SHC Patient, Aug 2020
Dr. Sarin is fantastic.. Her student Dr. Tu was excellent.
SHC Patient, Aug 2020
Consistently professional.
SHC Patient, Aug 2020
Dr. Sarvin is caring, efficient, knowledgeable.
SHC Patient, Jul 2020
Dr Sarin always explains everything clearly. She remembers medical and non-medical topics we've discussed in the past (which I find amazing, given the number of patients she deals with). Excellent bedside manner!
SHC Patient, May 2020
Dr. Sarin was courteous, friendly, professional, and thorough. I felt she was genuinely interested in me and my concerns. I would recommend her to any new patient.
SHC Patient, Apr 2020
Good experience.
SHC Patient, Mar 2020
Dr. Sarin is very thoughtful and responds to our concerns. She is also very thorough.
View All 137 Patient Comments »